<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK185329" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK185329/" /><meta name="ncbi_pagename" content="Mitochondrial Membrane Protein-Associated Neurodegeneration - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Mitochondrial Membrane Protein-Associated Neurodegeneration - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Mitochondrial Membrane Protein-Associated Neurodegeneration" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/02/27" /><meta name="citation_author" content="Allison Gregory" /><meta name="citation_author" content="Monika Hartig" /><meta name="citation_author" content="Holger Prokisch" /><meta name="citation_author" content="Tomasz Kmiec" /><meta name="citation_author" content="Penelope Hogarth" /><meta name="citation_author" content="Susan J Hayflick" /><meta name="citation_pmid" content="24575447" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK185329/" /><meta name="citation_keywords" content="NBIA4" /><meta name="citation_keywords" content="NBIA4" /><meta name="citation_keywords" content="Protein C19orf12" /><meta name="citation_keywords" content="C19orf12" /><meta name="citation_keywords" content="Mitochondrial Membrane Protein-Associated Neurodegeneration" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Mitochondrial Membrane Protein-Associated Neurodegeneration" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Allison Gregory" /><meta name="DC.Contributor" content="Monika Hartig" /><meta name="DC.Contributor" content="Holger Prokisch" /><meta name="DC.Contributor" content="Tomasz Kmiec" /><meta name="DC.Contributor" content="Penelope Hogarth" /><meta name="DC.Contributor" content="Susan J Hayflick" /><meta name="DC.Date" content="2014/02/27" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK185329/" /><meta name="description" content="Mitochondrial membrane protein-associated neurodegeneration (MPAN) is characterized initially by gait changes followed by progressive spastic paresis, progressive dystonia (which may be limited to the hands and feet or more generalized), neuropsychiatric abnormalities (e.g., emotional lability, depression, anxiety, impulsivity, compulsions, hallucinations, perseveration, inattention, and hyperactivity), and cognitive decline. Additional early findings can include dysphagia, dysarthria, optic atrophy, axonal neuropathy, parkinsonism, and bowel/bladder incontinence. Survival is usually well into adulthood. End-stage disease is characterized by severe dementia, spasticity, dystonia, and parkinsonism." /><meta name="og:title" content="Mitochondrial Membrane Protein-Associated Neurodegeneration" /><meta name="og:type" content="book" /><meta name="og:description" content="Mitochondrial membrane protein-associated neurodegeneration (MPAN) is characterized initially by gait changes followed by progressive spastic paresis, progressive dystonia (which may be limited to the hands and feet or more generalized), neuropsychiatric abnormalities (e.g., emotional lability, depression, anxiety, impulsivity, compulsions, hallucinations, perseveration, inattention, and hyperactivity), and cognitive decline. Additional early findings can include dysphagia, dysarthria, optic atrophy, axonal neuropathy, parkinsonism, and bowel/bladder incontinence. Survival is usually well into adulthood. End-stage disease is characterized by severe dementia, spasticity, dystonia, and parkinsonism." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK185329/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mt-mpan/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK185329/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B4AF2E03FA0F10000000007F802C1.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK185329_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK185329_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mt-overview/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mngie/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK185329_"><span class="title" itemprop="name">Mitochondrial Membrane Protein-Associated Neurodegeneration</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: NBIA4</div><p class="contrib-group"><span itemprop="author">Allison Gregory</span>, MS, CGC, <span itemprop="author">Monika Hartig</span>, MD, <span itemprop="author">Holger Prokisch</span>, PhD, <span itemprop="author">Tomasz Kmiec</span>, MD, <span itemprop="author">Penelope Hogarth</span>, MD, and <span itemprop="author">Susan J Hayflick</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK185329_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK185329_ai__"><div class="contrib half_rhythm"><span itemprop="author">Allison Gregory</span>, MS, CGC<div class="affiliation small">Genetic Counselor and Research Instructor, Oregon Health &#x00026; Science University<br />Portland, Oregon<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usho@ayrogerg" class="oemail">ude.usho@ayrogerg</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Monika Hartig</span>, MD<div class="affiliation small">Clinical Geneticist, Institute of Human Genetics<br />Technische Universit&#x000e4;t M&#x000fc;nchen<br />Munich, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.mut.dem.kitenegnamuh@gitrah.akinom" class="oemail">ed.mut.dem.kitenegnamuh@gitrah.akinom</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Holger Prokisch</span>, PhD<div class="affiliation small">Institute of Human Genetics<br />Technische Universit&#x000e4;t M&#x000fc;nchen<br />Munich, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.ehcneum-ztlohmleh@hcsikorp" class="oemail">ed.ehcneum-ztlohmleh@hcsikorp</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Tomasz Kmiec</span>, MD<div class="affiliation small">Associate Professor, Neurology<br />Children's Memorial Health Institute<br />Warsaw, Poland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@ceimkzsamot.rd" class="oemail">moc.liamg@ceimkzsamot.rd</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Penelope Hogarth</span>, MD<div class="affiliation small">Associate Professor, Molecular and Medical Genetics<br />Oregon Health &#x00026; Science University<br />Portland, Oregon<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usho@phtragoh" class="oemail">ude.usho@phtragoh</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Susan J Hayflick</span>, MD<div class="affiliation small">Professor and Chair, Molecular and Medical Genetics<br />Professor, Pediatrics and Neurology<br />Oregon Health &#x00026; Science University<br />Portland, Oregon<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.usho@kcilfyah" class="oemail">ude.usho@kcilfyah</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 27, 2014</span>.</p><p><em>Estimated reading time: 12 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mt-mpan.Summary" itemprop="description"><h2 id="_mt-mpan_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Mitochondrial membrane protein-associated neurodegeneration (MPAN) is characterized initially by gait changes followed by progressive spastic paresis, progressive dystonia (which may be limited to the hands and feet or more generalized), neuropsychiatric abnormalities (e.g., emotional lability, depression, anxiety, impulsivity, compulsions, hallucinations, perseveration, inattention, and hyperactivity), and cognitive decline. Additional early findings can include dysphagia, dysarthria, optic atrophy, axonal neuropathy, parkinsonism, and bowel/bladder incontinence. Survival is usually well into adulthood. End-stage disease is characterized by severe dementia, spasticity, dystonia, and parkinsonism.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of MPAN is confirmed in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>C19orf12</i>. (Although no non-molecular tests are able to reliably distinguish MPAN from other NBIA disorders, postmortem neuropathologic examination in individuals in whom molecular testing was not performed may help support the diagnosis of MPAN.)</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Pharmacologic treatment of spasticity, dystonia, and parkinsonism; psychiatric treatment of significant neuropsychiatric symptoms; physical, occupational, speech, and other therapies as indicated. Nutritional supplements and gastric feeding as needed. Management of excessive secretions and aspiration risk with glycopyrrolate, transdermal scopolamine patch, and/or tracheostomy as indicated.</p><p><i>Surveillance:</i> Routine follow up by a neurologist for medication management and interval assessment of ambulation, speech, and swallowing (often done every 3-6 months, but may be annual for patients who are more stable). Monitoring of patients receiving dopaminergic drugs for parkinsonism for adverse neuropsychiatric effects, and monitoring of patients receiving dopamine antagonist agents for psychiatric symptoms for the development or worsening of parkinsonism. Annual ophthalmologic examination is recommended.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>MPAN is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family have been identified. (Note: Possible <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance in one family has been reported.)</p></div></div><div id="mt-mpan.Diagnosis"><h2 id="_mt-mpan_Diagnosis_">Diagnosis</h2><div id="mt-mpan.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>While formal guidelines have not yet been developed to aid in the identification of mitochondrial membrane protein-associated neurodegeneration (MPAN), several of the predominant features of the disorder help distinguish it from other forms of <a href="/books/n/gene/nbia-ov/">neurodegeneration with brain iron accumulation</a> (NBIA).</p><p><b>The diagnosis of MPAN is suspected in individuals with the following:</b></p><ul><li class="half_rhythm"><div>Onset in childhood to early adulthood with slow progression and survival well into adulthood</div></li><li class="half_rhythm"><div>Cognitive decline progressing to severe dementia</div></li><li class="half_rhythm"><div>Prominent neuropsychiatric abnormalities including emotional lability, depression, anxiety, impulsivity, compulsions, hallucinations, perseveration, inattention, and hyperactivity</div></li><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Dystonia, often of the hands and feet</div></li><li class="half_rhythm"><div>Muscle weakness</div></li><li class="half_rhythm"><div>Early spasticity sometimes followed by flaccid paresis</div></li><li class="half_rhythm"><div>Babinski sign</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Iron accumulation observed on brain MRI in both the globus pallidus and substantia nigra (<a class="figpopup" href="/books/NBK185329/figure/mt-mpan.F1/?report=objectonly" target="object" rid-figpopup="figmtmpanF1" rid-ob="figobmtmpanF1">Figure 1B</a>). Serial MRI studies show that iron accumulation and brain atrophy progress with the disease course. To date, abnormal brain iron accumulation has been associated with all but two molecularly confirmed cases of MPAN (<a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sisters) [<a class="bk_pop" href="#mt-mpan.REF.landour_.2013.1357">Landour&#x000e9; et al 2013</a>] (see <a href="#mt-mpan.Genetically_Related_Allelic_Diso">Genetically Related Disorders</a>). Since most affected individuals are identified following abnormal brain MRI studies, this strong correlation may reflect ascertainment bias.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmtmpanF1" co-legend-rid="figlgndmtmpanF1"><a href="/books/NBK185329/figure/mt-mpan.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figmtmpanF1" rid-ob="figobmtmpanF1"><img class="small-thumb" src="/books/NBK185329/bin/mt-mpan-Image001.gif" src-large="/books/NBK185329/bin/mt-mpan-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndmtmpanF1"><h4 id="mt-mpan.F1"><a href="/books/NBK185329/figure/mt-mpan.F1/?report=objectonly" target="object" rid-ob="figobmtmpanF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Imaging in MPAN A. Typical eye-of-the-tiger sign seen in PKAN</p></div></div><p><b>The diagnosis of MPAN is further supported by the following findings:</b></p><ul><li class="half_rhythm"><div>Dysphagia</div></li><li class="half_rhythm"><div>Motor axonopathy with a pattern of distal denervation observed on electromyography and nerve conduction studies consistent with the clinical findings of distal to proximal loss of deep tendon reflexes.</div></li><li class="half_rhythm"><div>Parkinsonism (bradykinesia, rigidity, tremor, postural instability, and/or REM sleep behavior disorder)</div></li><li class="half_rhythm"><div>Incontinence of bowel and/or bladder</div></li><li class="half_rhythm"><div>On T<sub>2</sub>-weighted brain MRI some individuals have hyperintense streaking of the medial medullary lamina between the globus pallidus interna and externa that could be mistaken for an eye-of-the-tiger sign (<a class="figpopup" href="/books/NBK185329/figure/mt-mpan.F1/?report=objectonly" target="object" rid-figpopup="figmtmpanF1" rid-ob="figobmtmpanF1">Figure 1C</a>). Other less frequent MRI abnormalities include generalized cortical atrophy and cerebellar atrophy [<a class="bk_pop" href="#mt-mpan.REF.hogarth.2013.268">Hogarth et al 2013</a>, <a class="bk_pop" href="#mt-mpan.REF.schottmann.2014.290">Schottmann et al 2014</a>] and T<sub>1</sub>-weighted hyperintensity in the caudate nucleus and putamen [<a class="bk_pop" href="#mt-mpan.REF.schulte.2013.224">Schulte et al 2013</a>].</div></li></ul><p><b>The diagnosis of MPAN is confirmed</b> in individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>C19orf12</i> (<a class="figpopup" href="/books/NBK185329/table/mt-mpan.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figmtmpanTmoleculargenetictestingused" rid-ob="figobmtmpanTmoleculargenetictestingused">Table 1</a>). (Note: Although no non-molecular tests are able to reliably distinguish MPAN from other NBIA disorders, postmortem neuropathologic examination (see <a href="#mt-mpan.Neuropathology">Neuropathology</a>) in individuals in whom molecular testing was not performed may help support the diagnosis of MPAN.)</p><p>One <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> strategy is <b><a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a></b> of <i>C19orf12</i>, the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause MPAN.</p><p>Another <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> strategy is use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>C19orf12</i> and other genes of interest (see <a href="#mt-mpan.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="mt-mpan.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Mitochondrial Membrane Protein Associated with Neurodegeneration (MPAN)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK185329/table/mt-mpan.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mt-mpan.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mt-mpan.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_mt-mpan.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_mt-mpan.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_mt-mpan.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C19orf12</i></td><td headers="hd_h_mt-mpan.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_mt-mpan.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mt-mpan.TF.1.1"><p class="no_margin">See <a href="/books/NBK185329/#mt-mpan.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#mt-mpan.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="mt-mpan.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd></dl></div></div></div><div id="mt-mpan.Neuropathology"><h4>Neuropathology</h4><p>MPAN is characterized by increased iron deposition in the globus pallidus and substantia nigra. Neuronal loss, gliosis, widespread iron deposits, and eosinophilic spheroidal structures in the globus pallidus in MPAN are similar to the neuropathologic changes seen in <a href="/books/n/gene/pkan/">pantothenate kinase-associated neurodegeneration</a> (PKAN). In MPAN, however, widespread Lewy bodies throughout the neocortex, deep gray matter, and midbrain are more prominent than the findings observed in <a href="/books/n/gene/inad/"><i>PLA2G6</i>-associated neurodegeneration</a> (PLAN) and other forms of <a href="/books/n/gene/nbia-ov/">NBIA</a> [<a class="bk_pop" href="#mt-mpan.REF.hartig.2011.543">Hartig et al 2011</a>, <a class="bk_pop" href="#mt-mpan.REF.hogarth.2013.268">Hogarth et al 2013</a>].</p><p>Peripheral axonal spheroids, previously thought to be limited to <a href="/books/n/gene/inad/"><i>PLA2G6</i>-associated neurodegeneration</a> (PLAN), may be detected on skin or nerve biopsies [<a class="bk_pop" href="#mt-mpan.REF.kurian.2008.1623">Kurian et al 2008</a>, <a class="bk_pop" href="#mt-mpan.REF.hogarth.2013.268">Hogarth et al 2013</a>].</p></div></div></div><div id="mt-mpan.Clinical_Characteristics"><h2 id="_mt-mpan_Clinical_Characteristics_">Clinical Characteristics</h2><div id="mt-mpan.Clinical_Description"><h3>Clinical Description</h3><p>Onset of mitochondrial membrane protein-associated neurodegeneration (MPAN) typically occurs in childhood (3-16 years) to early adulthood (16-24 years) but has been reported as late as age 30 years. Among sibs the age of onset is similar.</p><p>The phenotypic spectrum of MPAN is likely to broaden as more cases are described. Fewer than 100 cases have been described to date.</p><p>Unlike in many other forms of <a href="/books/n/gene/nbia-ov/">neurodegeneration with brain iron accumulation</a> (NBIA), the progression of MPAN is usually slow with survival well into adulthood. However, rare individuals with abrupt adult onset and rapid progression have been reported [<a class="bk_pop" href="#mt-mpan.REF.dogu.2013.350">Dogu et al 2013</a>, <a class="bk_pop" href="#mt-mpan.REF.hogarth.2013.268">Hogarth et al 2013</a>].</p><p>Individuals with MPAN learn to walk and are usually mobile into early adulthood [<a class="bk_pop" href="#mt-mpan.REF.hartig.2011.543">Hartig et al 2011</a>]. The most common presenting feature is impaired gait. Some present with vision impairment associated with optic atrophy, which is more common in childhood-onset than adult-onset MPAN and is strongly associated with homozygosity for a common <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> <a class="figpopup" href="/books/NBK185329/table/mt-mpan.T.c19orf2_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figmtmpanTc19orf2pathogenicvariantsdi" rid-ob="figobmtmpanTc19orf2pathogenicvariantsdi">c.204_214del11</a> [<a class="bk_pop" href="#mt-mpan.REF.hartig.2011.543">Hartig et al 2011</a>, <a class="bk_pop" href="#mt-mpan.REF.hogarth.2013.268">Hogarth et al 2013</a>].</p><p>Early gait changes are typically followed by the onset of progressive spastic paresis. The lower limbs are usually affected earlier and more significantly than the upper limbs. Reflexes are initially brisk, and the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop extensor plantar responses. Later in the disease course, lower motor neuron signs emerge, with loss of deep tendon reflexes from distal to proximal, variably accompanied by muscle atrophy. In three families, juvenile-onset mixed upper and lower motor neuron dysfunction mimicking amyotrophic lateral sclerosis was the presenting and salient feature [<a class="bk_pop" href="#mt-mpan.REF.deschauer.2012.2434">Deschauer et al 2012</a>, <a class="bk_pop" href="#mt-mpan.REF.schottmann.2014.290">Schottmann et al 2014</a>].</p><p>Dystonia is also common and progressive. It may be limited to the hands and feet or more generalized. Dysarthria has been reported in most patients, and dysphagia in about half.</p><p>Parkinsonism also occurs in about half of individuals reported, with varying combinations of bradykinesia, rigidity, tremor, postural instability, and REM sleep behavior disorder. Parkinsonism is more common in adult-onset MPAN, particularly in those with rapid progression; however, it can develop late in the course of juvenile-onset MPAN.</p><p>Progressive cognitive decline is the norm in MPAN, in contrast to the common <a href="/books/n/gene/pkan/">pantothenate kinase-associated neurodegeneration</a> (PKAN) form of NBIA.</p><p>Neuropsychiatric changes are also frequent and varied; they include depression, anxiety, emotional lability, compulsions, hallucinations, perseveration, impulsivity, inattention, and hyperactivity.</p><p>While incontinence has been noted late in the course of other forms of NBIA, some individuals with MPAN develop this earlier in disease while they may still be ambulatory with little cognitive decline [<a class="bk_pop" href="#mt-mpan.REF.hogarth.2013.268">Hogarth et al 2013</a>].</p><p>The end stages of MPAN are characterized by severe dementia, spasticity, dystonia, and parkinsonism. Affected individuals are no longer ambulatory; communication is limited due to dysarthria and cognitive decline. Weight loss and bowel and/or bladder incontinence are common. Persons with advanced disease may have stereotypic hand or head movements with alterations in consciousness that do not appear to be related to seizures. Death typically occurs secondary to complications such as aspiration pneumonia.</p></div><div id="mt-mpan.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the common <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> <a class="figpopup" href="/books/NBK185329/table/mt-mpan.T.c19orf2_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figmtmpanTc19orf2pathogenicvariantsdi" rid-ob="figobmtmpanTc19orf2pathogenicvariantsdi">c.204_214del11</a>, reported originally in a Polish cohort, have childhood-onset disease with optic atrophy [<a class="bk_pop" href="#mt-mpan.REF.hartig.2011.543">Hartig et al 2011</a>, <a class="bk_pop" href="#mt-mpan.REF.hogarth.2013.268">Hogarth et al 2013</a>].</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK185329/table/mt-mpan.T.c19orf2_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figmtmpanTc19orf2pathogenicvariantsdi" rid-ob="figobmtmpanTc19orf2pathogenicvariantsdi">c.32C&#x0003e;T</a> is associated with later disease onset (mean age of 25 years for persons <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for c.32C&#x0003e;T) compared to a mean age of ten years for all published cases [<a class="bk_pop" href="#mt-mpan.REF.hartig.2013.73">Hartig et al 2013</a>].</p></div><div id="mt-mpan.Prevalence"><h3>Prevalence</h3><p>MPAN is a newly recognized form of NBIA with a prevalence roughly estimated at less than one in 1,000,000. Fewer than 100 cases with molecular confirmation have been described to date.</p><p>As the awareness of MPAN increases and molecular testing is used more frequently, a better estimation may be made.</p></div></div><div id="mt-mpan.Genetically_Related_Allelic_Diso"><h2 id="_mt-mpan_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>Homozygosity for a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>C19orf12</i> (<a class="figpopup" href="/books/NBK185329/table/mt-mpan.T.c19orf2_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figmtmpanTc19orf2pathogenicvariantsdi" rid-ob="figobmtmpanTc19orf2pathogenicvariantsdi">c.187G&#x0003e;C</a>; p.Ala63Pro) was found in two Malian sisters with hereditary spastic paraplegia type 43 (SPG43) [<a class="bk_pop" href="#mt-mpan.REF.landour_.2013.1357">Landour&#x000e9; et al 2013</a>]. While brain MRI did not reveal any evidence for iron accumulation in either, the same pathogenic variant has been identified in at least two other families with NBIA, arguing against a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> correlation.</p><p>Although this finding was only reported in one instance, it suggests the possibility that <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>C19orf12</i> pathogenic variants could be disease causing in individuals with neurodegeneration who have no evidence of brain iron accumulation at the time of investigation.</p></div><div id="mt-mpan.Differential_Diagnosis"><h2 id="_mt-mpan_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="/books/n/gene/nbia-ov/">Neurodegeneration with Brain Iron Accumulation (NBIA) Overview</a>. Of note, MPAN appears to be the third most common NBIA, after <a href="/books/n/gene/pkan/">PKAN</a> and <a href="/books/n/gene/inad/">PLAN</a>.</p></div><div id="mt-mpan.Management"><h2 id="_mt-mpan_Management_">Management</h2><div id="mt-mpan.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with mitochondrial membrane protein-associated neurodegeneration (MPAN), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Complete neurologic examination, including evaluation of ambulation, speech, and swallowing</div></li><li class="half_rhythm"><div>Ophthalmologic examination to assess for optic atrophy</div></li><li class="half_rhythm"><div>Assessment by specialists in physical, occupational, and/or speech therapy</div></li><li class="half_rhythm"><div>Brain MRI (T<sub>2</sub>-weighted at a minimum) if one has not been obtained within the past two years</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="mt-mpan.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following are indicated:</p><ul><li class="half_rhythm"><div>Pharmacologic treatment of dystonia and spasticity, including consideration of oral baclofen, trihexyphenidyl, intramuscular botulinum toxin, and a trial of intrathecal baclofen if indicated</div></li><li class="half_rhythm"><div>Pharmacologic treatment of parkinsonism (response to levodopa has been variable in this population)</div></li><li class="half_rhythm"><div>Treatment by a psychiatrist for those with significant neuropsychiatric symptoms</div></li><li class="half_rhythm"><div>Physical, occupational, speech, and other therapies as indicated</div></li><li class="half_rhythm"><div>Use of a liquid nutritional supplement to help maintain weight as needed</div></li><li class="half_rhythm"><div>A gastric feeding tube to help minimize weight loss (which becomes more frequent with disease progression) and to reduce the risk of aspiration pneumonia</div></li><li class="half_rhythm"><div>Glycopyrrolate or transdermal scopolamine patch to reduce the volume of secretions in those with excessive drooling or difficulty controlling secretions</div></li><li class="half_rhythm"><div>Tracheostomy as indicated for difficulty managing secretions</div></li><li class="half_rhythm"><div>Over-the-counter fiber supplements and/or stool softeners to treat constipation, which is likely caused by a combination of immobility, diet, and medications</div></li></ul></div><div id="mt-mpan.Surveillance"><h3>Surveillance</h3><p>Patients are typically followed most closely by a neurologist for medication management and for interval assessment of ambulation, speech, and swallowing. This is often done every three to six months, but may be annual for patients who are more stable.</p><p>Patients receiving dopaminergic drugs (for parkinsonism) are monitored for adverse neuropsychiatric effects; conversely, patients receiving typical or atypical dopamine antagonist agents (for psychiatric features) are monitored for the development or worsening of parkinsonism.</p><p>Annual ophthalmologic examination is recommended.</p></div><div id="mt-mpan.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#mt-mpan.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="mt-mpan.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Deep brain stimulation (DBS) has not been specifically studied in MPAN, even in case reports. DBS has become a common treatment for primary dystonia and is being used more frequently to attempt to treat the secondary dystonia in <a href="/books/n/gene/pkan/">PKAN</a> with some success. It is likely that the use of DBS in MPAN will eventually be reported.</p><p>Iron chelation using deferiprone is currently under investigation in <a href="/books/n/gene/pkan/">PKAN</a> (see <a href="http://clinicaltrials.gov/ct2/show/NCT01741532?term=pkan+AND+deferiprone&#x00026;rank=1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a>). A small Phase II pilot trial in PKAN showed statistically significant reduction of brain iron by MRI evaluation; however, no change in clinical status was observed [<a class="bk_pop" href="#mt-mpan.REF.zorzi.2011.1756">Zorzi et al 2011</a>]. The current double-blind, placebo-controlled trial in PKAN may inform whether deferiprone treatment should be considered for MPAN.</p><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="mt-mpan.Genetic_Counseling"><h2 id="_mt-mpan_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="mt-mpan.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Mitochondrial membrane protein-associated neurodegeneration (MPAN) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p>Note: Possible <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance in one family has been reported [<a class="bk_pop" href="#mt-mpan.REF.hogarth.2013.268">Hogarth et al 2013</a>].</p></div><div id="mt-mpan.Risk_to_Family_Members__Autosoma"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with MPAN has children with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>C19orf12</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="mt-mpan.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p></div><div id="mt-mpan.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b>Fibroblast cell line banking</b> should be considered if fibroblast cells of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are available.</p></div><div id="mt-mpan.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for MPAN are possible.</p></div></div><div id="mt-mpan.Resources"><h2 id="_mt-mpan_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>NBIA Alliance</b></div><div><b>Email:</b> Info@NBIAalliance.org</div><div><a href="http://www.nbiaalliance.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nbiaalliance.org</a></div></li><li class="half_rhythm"><div><b>NBIA Disorders Association</b></div><div>2082 Monaco Court</div><div>El Cajon CA 92019-4235</div><div><b>Phone:</b> 619-588-2315</div><div><b>Fax:</b> 619-588-4093</div><div><b>Email:</b> info@NBIAdisorders.org</div><div><a href="https://www.nbiadisorders.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nbiadisorders.org</a></div></li><li class="half_rhythm"><div><b>NBIA Disorders Association Research Registry and Treat Iron-Related Childhood-Onset Neurodegeneration (TIRCON) Registry</b></div><div> CA 92019-4235</div><div><b>Phone:</b> 619-588-2315</div><div><b>Fax:</b> 619-588-4093</div><div><b>Email:</b> pwood@nbiadisorders.org</div><div><a href="http://www.nbiadisorders.org/research/patient-registry?highlight=YToxOntpOjA7czo4OiJyZWdpc3RyeSI7fQ==" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Patient Registry &#x00026; Biomaterial Bank</a></div></li><li class="half_rhythm"><div><b>NBIAcure</b></div><div>Center of Excellence for NBIA Clinical Care and Research</div><div>International Registry for NBIA and Related Disorders</div><div>Oregon Health &#x00026; Science University</div><div><b>Phone:</b> 503-494-4344</div><div><b>Fax:</b> 503-494-6886</div><div><b>Email:</b> gregorya@ohsu.edu</div><div><a href="http://nbiacure.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nbiacure.org</a></div></li><li class="half_rhythm"><div><b>Treat Iron-Related Childhood Onset Neurodegeneration (TIRCON) Registry</b></div><div>Germany</div><div><b>Phone:</b> 49-89-5160-7421</div><div><b>Fax:</b> 49-89-5160-7402</div><div><b>Email:</b> tircon@med.uni-muenchen.de</div><div><a href="http://tircon.eu/tircon-workpackages/wp1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://tircon.eu/tircon-workpackages/wp1</a></div></li></ul></div><div id="mt-mpan.Molecular_Genetics"><h2 id="_mt-mpan_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="mt-mpan.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Mitochondrial Membrane Protein-Associated Neurodegeneration: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK185329/table/mt-mpan.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mt-mpan.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_mt-mpan.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_mt-mpan.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_mt-mpan.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_mt-mpan.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_mt-mpan.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_mt-mpan.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/83636" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>C19orf12</i></a></td><td headers="hd_b_mt-mpan.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=83636" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19q12</a></td><td headers="hd_b_mt-mpan.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NSK7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Protein C19orf12</a></td><td headers="hd_b_mt-mpan.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=C19orf12" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">C19orf12</a></td><td headers="hd_b_mt-mpan.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=C19orf12[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">C19orf12</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="mt-mpan.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="mt-mpan.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Mitochondrial Membrane Protein-Associated Neurodegeneration (<a href="/omim/614297,614298" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK185329/table/mt-mpan.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mt-mpan.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614297" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614297</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHROMOSOME 19 OPEN READING FRAME 12; C19ORF12</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614298" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614298</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>C19orf12</i> comprises three exons that span less than 17 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequence. In humans there are two transcript variants, the longest being <a href="/nuccore/NM_001031726.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001031726.3</a>. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK185329/#mt-mpan.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> A common <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>, <a class="figpopup" href="/books/NBK185329/table/mt-mpan.T.c19orf2_pathogenic_variants_di/?report=objectonly" target="object" rid-figpopup="figmtmpanTc19orf2pathogenicvariantsdi" rid-ob="figobmtmpanTc19orf2pathogenicvariantsdi">c.204_214del11</a>, has been observed in persons of eastern European descent (mainly Polish) [<a class="bk_pop" href="#mt-mpan.REF.hartig.2011.543">Hartig et al 2011</a>]. Most families have <a class="def" href="/books/n/gene/glossary/def-item/private/">private</a> pathogenic variants. Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants are distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>.</p><div id="mt-mpan.T.c19orf2_pathogenic_variants_di" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>C19orf2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK185329/table/mt-mpan.T.c19orf2_pathogenic_variants_di/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mt-mpan.T.c19orf2_pathogenic_variants_di_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.32C&#x0003e;T&#x000a0;<sup>1,&#x000a0;2</sup></td><td headers="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr11Met</td><td headers="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001031726.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001031726<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_001026896.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001026896<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.187G&#x0003e;C</td><td headers="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala63Pro&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.204_214del11</td><td headers="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly69ArgfsTer10</td></tr><tr><td headers="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.205G&#x0003e;A</td><td headers="hd_h_mt-mpan.T.c19orf2_pathogenic_variants_di_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly69Arg</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="mt-mpan.TF.2.1"><p class="no_margin">See <a href="#mt-mpan.Genetically_Related_Allelic_Diso">Genetically Related Disorders</a>.</p></div></dd><dt>2. </dt><dd><div id="mt-mpan.TF.2.2"><p class="no_margin">See <a href="#mt-mpan.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The two protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> in humans have 141 and 152 amino acids, <a href="/protein/NP_001242976.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>NP_001242976.1</u></a> and <a href="/protein/NP_001026896.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001026896.2</a>, respectively. The protein localizes predominantly to the mitochondria [<a class="bk_pop" href="#mt-mpan.REF.hartig.2011.543">Hartig et al 2011</a>]; little is known about its function.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Association with the mitochondrial membrane and co-regulation with proteins of fatty acid biogenesis and branched chain amino acid degradation expression profiles suggest similarities to other proteins known to be defective in NBIA. Protein C19orf12 is suspected to play a role in lipid homeostasis [<a class="bk_pop" href="#mt-mpan.REF.hartig.2011.543">Hartig et al 2011</a>].</p></div><div id="mt-mpan.References"><h2 id="_mt-mpan_References_">References</h2><div id="mt-mpan.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.deschauer.2012.2434">Deschauer M, Gaul C, Behrmann C, Prokisch H, Zierz S, Haack TB. C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. <span><span class="ref-journal">J Neurol. </span>2012;<span class="ref-vol">259</span>:2434–9.</span> [<a href="/pubmed/22584950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22584950</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.dogu.2013.350">Dogu O, Krebs CE, Kaleagasi H, Demirtas Z, Oksuz N, Walker RH, Pais&#x000e1;n-Ruiz C. Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">84</span>:350–5.</span> [<a href="/pubmed/23278385" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23278385</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.hartig.2013.73">Hartig M, Prokisch H, Meitinger T, Klopstock T. Mitochondrial membrane protein-associated neurodegeneration (MPAN). <span><span class="ref-journal">Int Rev Neurobiol. </span>2013;<span class="ref-vol">110</span>:73–84.</span> [<a href="/pubmed/24209434" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24209434</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.hartig.2011.543">Hartig MB, Iuso A, Haack T, Kmiec T, Jurkiewicz E, Heim K, Roeber S, Tarabin V, Dusi S, Krajewska-Walasek M, Jozwiak S, Hempel M, Winkelmann J, Elstner M, Oexle K, Klopstock T, Mueller-Felber W, Gasser T, Trenkwalder C, Tiranti V, Kretzschmar H, Schmitz G, Strom TM, Meitinger T, Prokisch H. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:543–50.</span> [<a href="/pmc/articles/PMC3188837/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3188837</span></a>] [<a href="/pubmed/21981780" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21981780</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.hogarth.2013.268">Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, Diedrich A, Green S, Tran H, Reese L, Woltjer RL, Hayflick SJ. New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:268–75.</span> [<a href="/pmc/articles/PMC3589182/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3589182</span></a>] [<a href="/pubmed/23269600" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23269600</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.kurian.2008.1623">Kurian MA, Morgan NV, MacPherson L, Foster K, Peake D, Gupta R, Philip SG, Hendriksz C, Morton JE, Kingston HM, Rosser EM, Wassmer E, Gissen P, Maher ER. Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">70</span>:1623–9.</span> [<a href="/pubmed/18443314" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18443314</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.landour_.2013.1357">Landour&#x000e9; G, Zhu PP, Louren&#x000e7;o CM, Johnson JO, Toro C, Bricceno KV, Rinaldi C, Meilleur KG, Sangar&#x000e9; M, Diallo O, Pierson TM, Ishiura H, Tsuji S, Hein N, Fink JK, Stoll M, Nicholson G, Gonzalez MA, Speziani F, D&#x000fc;rr A, Stevanin G, Biesecker LG, Accardi J, Landis DM, Gahl WA, Traynor BJ, Marques W Jr, Z&#x000fc;chner S, Blackstone C, Fischbeck KH, Burnett BG, et al.  Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. <span><span class="ref-journal">Hum Mutat. </span>2013;<span class="ref-vol">34</span>:1357–60.</span> [<a href="/pmc/articles/PMC3819934/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3819934</span></a>] [<a href="/pubmed/23857908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23857908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.schottmann.2014.290">Schottmann G, Stenzel W, L&#x000fc;tzkendorf S, Schuelke M, Knierim E. A novel frameshift mutation of C19ORF12 causes NBIA4 with cerebellar atrophy and manifests with severe peripheral motor axonal neuropathy. <span><span class="ref-journal">Clin Genet. </span>2014;<span class="ref-vol">85</span>:290–2.</span> [<a href="/pubmed/23521069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23521069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.schulte.2013.224">Schulte EC, Claussen MC, Jochim A, Haack T, Hartig M, Hempel M, Prokisch H, Haun-J&#x000fc;nger U, Winkelmann J, Hemmer B, F&#x000f6;rschler A, Ilg R. Mitochondrial membrane protein associated neurodegeneration: a novel variant of neurodegeneration with brain iron accumulation. <span><span class="ref-journal">Mov Disord. </span>2013;<span class="ref-vol">28</span>:224–7.</span> [<a href="/pubmed/23436634" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23436634</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mt-mpan.REF.zorzi.2011.1756">Zorzi G, Zibordi F, Chiapparini L, Bertini E, Russo L, Piga A, Longo F, Garavaglia B, Aquino D, Savoiardo M, Solari A, Nardocci N. Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. <span><span class="ref-journal">Mov Disord. </span>2011;<span class="ref-vol">26</span>:1756–9.</span> [<a href="/pubmed/21557313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21557313</span></a>]</div></li></ul></div></div><div id="mt-mpan.Chapter_Notes"><h2 id="_mt-mpan_Chapter_Notes_">Chapter Notes</h2><div id="mt-mpan.Acknowledgments"><h3>Acknowledgments</h3><p>Authors acknowledge funding from the European Commission Seventh Framework Programme (FP7/2007-2013, HEALTH-F2-2011, grant agreement No. 277984, TIRCON).</p></div><div id="mt-mpan.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>27 February 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>3 September 2013 (ag) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK185329</span><span class="label">PMID: <a href="/pubmed/24575447" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">24575447</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mt-overview/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mngie/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK185329&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK185329/?report=reader">PubReader</a></li><li><a href="/books/NBK185329/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK185329" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK185329" style="display:none" title="Cite this Page"><div class="bk_tt">Gregory A, Hartig M, Prokisch H, et al. Mitochondrial Membrane Protein-Associated Neurodegeneration. 2014 Feb 27. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK185329/pdf/Bookshelf_NBK185329.pdf">PDF version of this page</a> (262K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mt-mpan.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mt-mpan.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#mt-mpan.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#mt-mpan.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#mt-mpan.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#mt-mpan.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#mt-mpan.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#mt-mpan.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mt-mpan.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#mt-mpan.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mt-mpan.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=83636[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">C19orf12</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3072820" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3072820" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3072820" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3072820" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301718" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301791" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cohen BH, Chinnery PF, Copeland WC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22934317" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystonia/Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystonia/Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tuschl K, Clayton PT, Gospe SM Jr, Mills PB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28541650" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SLC39A14 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SLC39A14 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tuschl K, Gregory A, Meyer E, Clayton PT, Hayflick SJ, Mills PB, Kurian MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24575447" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24575447" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04100fdde0891169836bc4">Mitochondrial Membrane Protein-Associated Neurodegeneration - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Mitochondrial Membrane Protein-Associated Neurodegeneration - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:42:39-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B4AF2E03FA0F10000000007F802C1&amp;ncbi_session=CE8B4AF2E04100F1_2040SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK185329%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK185329&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK185329/&amp;ncbi_pagename=Mitochondrial Membrane Protein-Associated Neurodegeneration - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B4AF2E04100F1_2040SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>